Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 28
Item hits:
Issue DateTitleAuthor(s)
1-Jul-2018The burden of illness of idiopathic pulmonary fibrosis: a comprehensive evidence reviewDiamantopoulos, A; Wright, E; Vlahopoulou, K; Cornic, L; Schoof, N, et al
20-Aug-2018Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trialMaher, TM; Stowasser, S; Nishioka, Y; White, ES; Cottin, V, et al
15-Apr-2018Identification of diagnostic criteria for chronic hypersensitivity pneumonitis: an international modified Delphi surveyMorisset, J; Johannson, KA; Jones, KD; Wolters, PJ; Collard, HR, et al
1-Jun-2018Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysemaJacob, J; Bartholmai, BJ; Rajagopalan, S; Karwoski, R; Nair, A, et al
15-Jul-2018Rapidly progressive cystic lung diseaseRogers, C; Kent-Bramer, J; Devaraj, A; Nicholson, AG; Molyneaux, PL, et al
19-Oct-2018Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practiceFletcher, SV; Jones, MG; Renzoni, EA; Parfrey, H; Hoyles, RK, et al
19-Nov-2018Long-term safety of pirfenidone: results of the prospective, observational PASSPORT studyCottin, V; Koschel, D; G├╝nther, A; Albera, C; Azuma, A, et al
1-Oct-2018Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialVisca, D; Mori, L; Tsipouri, V; Fleming, S; Firouzi, A, et al
1-May-2018Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)Win, T; Screaton, NJ; Porter, JC; Ganeshan, B; Maher, TM, et al
1-Jul-2018Pulmonary hypertension in interstitial lung disease: limitations of echocardiography compared to cardiac catheterizationKeir, GJ; John Wort, S; Kokosi, M; George, PM; Walsh, SLF, et al